Cardium Obtains CE Marking for RapidBlue System

Cardium Therapeutics and its operating unit InnerCool Therapies received CE Marking for InnerCool’s RapidBlue endovascular temperature modulation system for inducing, maintaining and reversing mild hypothermia in clinical settings.

The system uses a programmable console with a touch-panel screen to manage and control desired patient body temperatures after circulating cool or warm saline through an inserted catheter.

The company said it expects to begin selling the system in Europe and other countries next quarter. The system is under review for FDA 510(k) clearance.